Use of phage display to isolate specific human monoclonal antibody fragments against a potential target for multiple myeloma.
Multiple myeloma (MM), a malignancy of plasma cells, accounts for 10% of all haematological malignancies and is currently incurable. Although it can be treated, the disease tends to relapse after several years and becomes increasingly resistant to conventional therapy. Investigations into using humoral therapy for MM are now underway with a view that novel therapeutic agents may provide a more targeted therapy for MM.
Version: za2963e q8za2 q8zbe q8zc4 q8zda q8ze8 q8zf2 q8zgf